Treatment Mode Preferences in Rheumatoid Arthritis: Moving Toward Shared Decision-Making

References

• Scott DL, Wolfe F, Huizinga TW. Rheumatoid arthritis. Lancet. 2010;376(9746):1094–1108. doi:10.1016/S0140-6736(10)60826-4
   PubMed Web of Science ®Google Scholar
• Cross M, Smith E, Hoy D, et al. The global burden of rheumatoid arthritis: estimates from the global burden of disease 2010 study. Ann Rheum Dis. 2014;73(7):1316–1322. doi:10.1136/annrheumdis-2013-204627
   PubMed Web of Science ®Google Scholar
• Aletaha D, Neogi T, Silman AJ, et al. 2010 Rheumatoid arthritis classification criteria: an American College of Rheumatology/European League Against Rheumatism collaborative initiative. Arthritis Rheum. 2010;62(9):2569–2581. doi:10.1002/art.27584
   PubMed Web of Science ®Google Scholar
• Scott IC, Machin A, Mallen CD, Hider SL. The extra-articular impacts of rheumatoid arthritis: moving towards holistic care. BMC Rheumatol. 2018;2:32. doi:10.1186/s41927-018-0039-2
   Google Scholar
• Singh JA, Saag KG, Bridges SL Jr, et al. 2015 American College of Rheumatology guideline for the treatment of rheumatoid arthritis. Arthritis Rheumatol. 2016;68(1):1–26. doi:10.1002/art.39480
   PubMed Web of Science ®Google Scholar
• Smolen JS, Landewé R, Bijlsma J, et al. EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2016 update. Ann Rheum Dis. 2017;76(6):960–977. doi:10.1136/annrheumdis-2016-210715
   PubMed Web of Science ®Google Scholar
• Goodman SM, Cronstein BN, Bykerk VP. Outcomes related to methotrexate dose and route of administration in patients with rheumatoid arthritis: a systematic literature review. Clin Exp Rheumatol. 2015;33(2):272–278.
   Web of Science ®Google Scholar
• Australian Rheumatology Association. Things to consider when taking a biologic; 2017. Available from: https://arthritisaustralia.com.au/wordpress/wp-content/uploads/2018/01/Things-To-Consider-Biologic_PDF-final_180124.pdf. Accessed March 15, 2019.
   Google Scholar
• Gibofsky A, Galloway J, Kekow J, et al. Comparison of patient and physician perspectives in the management of rheumatoid arthritis: results from global physician- and patient-based surveys. Health Qual Life Outcomes. 2018;16(1):211. doi:10.1186/s12955-018-1035-3
   PubMed Web of Science ®Google Scholar
• Zhu B, Chang L, Qian L, Larmore CJ, Tanaka Y, Araujo AB. RA medication preferences among U.S. patients in an online rheumatoid arthritis community. Arthritis Rheumatol. 2016;68 Suppl 10:2238.
   Google Scholar
• Fraenkel L, Bogardus ST, Concato J, Felson DT, Wittink DR. Patient preferences for treatment of rheumatoid arthritis. Ann Rheum Dis. 2004;63(11):1372–1378. doi:10.1136/ard.2003.019422
   PubMed Web of Science ®Google Scholar
• Louder AM, Singh A, Saverno K, et al. Patient preferences regarding rheumatoid arthritis therapies: a conjoint analysis. Am Health Drug Benefits. 2016;9(2):84–93.
   PubMed Web of Science ®Google Scholar
• Augustovski F, Beratarrechea A, Irazola V, et al. Patient preferences for biologic agents in rheumatoid arthritis: a discrete-choice experiment. Value Health. 2013;16(2):385–393. doi:10.1016/j.jval.2012.11.007
   PubMed Web of Science ®Google Scholar
• Harrison M, Marra C, Shojania K, Bansback N. Societal preferences for rheumatoid arthritis treatments: evidence from a discrete choice experiment. Rheumatology (Oxford). 2015;54(10):1816–1825. doi:10.1093/rheumatology/kev113
   Web of Science ®Google Scholar
• Barclay N, Tarallo M, Hendrikx T, Marett S. Patient preference for oral versus injectable and intravenous methods of treatment for rheumatoid arthritis. At: 16th Annual European Congress of the International Society of Pharmacoeconomics and Outcomes Research (ISPOR-EU); November 2–6; 2013; Dublin, Ireland.
   Google Scholar
• Taylor PC, Rieke A, Gomez-Reino JJ, et al. Mode of administration in rheumatoid arthritis treatments: an exploration of patient preference for an ‘ideal treatment’. Arthritis Rheumatol. 2016;68 Suppl 10:2492.
   Web of Science ®Google Scholar
• Alten R, Krüger K, Rellecke J, et al. Examining patient preferences in the treatment of rheumatoid arthritis using a discrete-choice approach. Patient Prefer Adherence. 2016;10:2217–2228. doi:10.2147/PPA.S117774
   PubMed Web of Science ®Google Scholar
• Kumar K, Klocke R. Ethnicity in rheumatic disease. Clin Med (Lond). 2010;10(4):370–372. doi:10.7861/clinmedicine.10-4-370
   Web of Science ®Google Scholar
• Barton JL, Trupin L, Schillinger D, et al. Racial and ethnic disparities in disease activity and function among persons with rheumatoid arthritis from university-affiliated clinics. Arthritis Care Res (Hoboken). 2011;63(9):1238–1246. doi:10.1002/acr.20525
   PubMed Web of Science ®Google Scholar
• Greenberg JD, Spruill TM, Shan Y, et al. Racial and ethnic disparities in disease activity in patients with rheumatoid arthritis. Am J Med. 2013;126(12):1089–1098. doi:10.1016/j.amjmed.2013.09.002
   PubMed Web of Science ®Google Scholar
• Bruce B, Fries JF, Murtagh KN. Health status disparities in ethnic minority patients with rheumatoid arthritis: a cross-sectional study. J Rheumatol. 2007;34(7):1475–1479.
   PubMed Web of Science ®Google Scholar
• Yazici Y, Kautiainen H, Sokka T. Differences in clinical status measures in different ethnic/racial groups with early rheumatoid arthritis: implications for interpretation of clinical trial data. J Rheumatol. 2007;34(2):311–315.
   Web of Science ®Google Scholar
• Tan BE, Lim AL, Kan SL, et al. Management of rheumatoid arthritis in clinical practice using treat-to-target strategy: where do we stand in the multi-ethnic Malaysia population? Rheumatol Int. 2017;37(6):905–913. doi:10.1007/s00296-017-3705-6
   Web of Science ®Google Scholar
• Braun V, Clarke V. Using thematic analysis in psychology. Qual Res Psychol. 2006;3(2):77–101. doi:10.1191/1478088706qp063oa
   Google Scholar
• SAS Proprietary Software, Version 9.4 [Computer Program]. Cary, NC: SAS Institute Inc.
   Google Scholar